XML 47 R30.htm IDEA: XBRL DOCUMENT v3.19.1
Financial Instruments and Financial Risk Management (Tables)
 12 Months Ended
Dec. 31, 2018
Financial Instruments and Financial Risk Management [Abstract]  
Schedule of analyzes non-derivative financial liabilities

   Less than one year   Between one to two years 
   U.S. dollars in thousands 
December 31, 2018:    
IIA liability   49    82 
Trade payables and other payables   1,054    - 
    1,103    82 
December 31, 2017:          
IIA liability   92    - 
Trade payables and other payables   1,055    - 
    1,147    - 
Schedule of changes in level 3 instruments

   Anti-dilution feature   Derivative financial instruments   Total 
   U.S. dollar in thousands 
Balance as of January 1, 2018   692    61    753 
Initial recognition   497    2,678    3,175 
Finance expenses   598    1,641    2,239 
Classification to equity of Series B warrants   -    (3,479)   (3,479)
Classification to level 1 (see Note 13(e))   -    (901)   (901)
Exercise of anti-dilution feature   (1,787)   -    (1,787)
Balance as of December 31, 2018   -    -    - 
Total unrealized losses for the period included in profit or loss for liabilities held at December 31, 2018   598    1,641    2,239 

 

   Anti-dilution feature   Derivative financial instruments   Total 
   U.S. dollar in thousands 
Balance as of January 1, 2017   94    -    94 
Initial recognition   315    1,958    2,273 
Finance expenses (income)   283    (1,897)   (1,614)
Balance as of December 31, 2017   692    61    753 
Total unrealized losses (gains) for the period included in profit or loss for liabilities held at December 31, 2017   283    (1,897)   (1,614)
                
   Anti-dilution feature   Options to group of investors   Bridge loan   Financing of issuance expenses   Total 
   U.S. dollar in thousands 
Balance as of January 1, 2016  -   -   *   *   * 
Initial recognition   106    193    -    -    299 
Finance expenses (income)   (12)   -    800**   256**   1,044 
Settlement/cancellation   -    (193)   (800)   (256)   (1,249)
Balance as of December 31, 2016   94    -    -    -    94 
Total unrealized gains for the period included in profit or loss for liabilities held at December 31, 2016   (12)   -    -    -    (12)

 

*Represents an amount of less than $ 1 thousands.
**Recognition of deferred initial loss at an amount equal to the cash amount paid by the Company at the time of completion the Merger Transaction.

Schedule of financial instruments

   Financial assets at amortized cost 
December 31, 2018  U.S. dollars
in thousands		 
Assets:     
Cash and cash equivalents   3,717 
Trade receivable and other receivables (excluding prepaid expenses)   910 
Restricted deposits   104 
    4,731 

 

   Loans and receivables 
December 31, 2017  U.S. dollars
in thousands		 
Assets:     
Cash and cash equivalents   3,514 
Trade receivable and other receivables (excluding prepaid expenses)   740 
Restricted deposits   93 
    4,347 

 

   Liabilities at fair value through profit or loss  

 

Financial liabilities at amortized cost

   Total 
December 31, 2018  U.S. dollars in thousands 
Liabilities:            
Trade payables and other payables   -    1,054    1,054 
IIA liability   -    131    131 
Derivative financial instruments   729    -    729 
    729    1,185    1,914 
December 31, 2017               
Liabilities:               
Trade payables and other payables   -    1,055    1,055 
IIA liability   -    92    92 
Derivative financial instruments   237    -    237 
Liability in respect of anti-dilution feature   692    -    692 
    929    1,147    2,076